PERSISTENT EFFECTS OF (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY) ON HUMAN SLEEP

被引:89
|
作者
ALLEN, RP
MCCANN, UD
RICAURTE, GA
机构
[1] NIMH, BIOL PSYCHIAT BRANCH, ANXIETY & AFFECT DISORDERS SECT, BLDG 10, BETHESDA, MD 20892 USA
[2] JOHNS HOPKINS UNIV, SCH MED, FRANCIS SCOTT KEY MED CTR, DEPT NEUROL, BALTIMORE, MD 21205 USA
来源
SLEEP | 1993年 / 16卷 / 06期
关键词
MDMA; SEROTONIN; NEUROTOXICITY; AMPHETAMINES; SLEEP;
D O I
10.1093/sleep/16.6.560
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
(+/-)3,4-methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin neurons in animals. It is not known whether MDMA is also neurotoxic in humans, and if so, whether there are functional consequences. Given the putative role of serotonin in sleep, it was hypothesized that one manifestation of serotonin neurotoxicity in humans might be disturbances of sleep. To determine whether MDMA use has effects on sleep, all-night polysomnograms of 23 MDMA users were compared to those of 22 age- and sex-matched controls. On average, MDMA users had 19 minutes less total sleep and 23.2 minutes less non-REM (NREM) sleep than controls. These statistically significant differences in NREM sleep were due primarily to an average of 37 minutes less stage 2 sleep, with no significant differences noted in stages 1, 3 or 4. Although it is not known whether the alterations in sleep observed in MDMA users are due to serotonin neurotoxicity, the present findings suggest that MDMA use can lead to persistent changes in CNS structures involved in human sleep generation.
引用
收藏
页码:560 / 564
页数:5
相关论文
共 50 条
  • [41] A new cause of valvular heart disease: 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy')
    Montastruc, F.
    Montastruc, G.
    Vigreux, P.
    Bruneval, P.
    Guilbeau-Frocher, C.
    Cron, C.
    Bagheri, H.
    Delisle, B.
    Lapeyre-Mestre, M.
    Pathak, A.
    Montastruc, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 10 - 10
  • [42] Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
    Taurah, Lynn
    Chandler, Chris
    Sanders, Geoff
    PSYCHOPHARMACOLOGY, 2014, 231 (04) : 737 - 751
  • [43] Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')
    Montastruc, Francois
    Montastruc, Guillaume
    Vigreux, Philippe
    Bruneval, Patrick
    Guilbeau-Frugier, Celine
    Cron, Christophe
    Bagheri, Haleh
    Delisle, Bernadette
    Lapeyre-Mestre, Maryse
    Pathak, Atul
    Montastruc, Jean-Louis
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (03) : 547 - 548
  • [44] REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY)
    GREEN, AR
    CROSS, AJ
    GOODWIN, GM
    PSYCHOPHARMACOLOGY, 1995, 119 (03) : 247 - 260
  • [45] Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study
    U. D. McCann
    Melissa Mertl
    Victoria Eligulashvili
    George A. Ricaurte
    Psychopharmacology, 1999, 143 : 417 - 425
  • [46] Behavioral Effects and Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons
    Goodwin, Amy K.
    Mueller, Melanie
    Shell, Courtney D.
    Ricaurte, George A.
    Ator, Nancy A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (03): : 342 - 353
  • [47] Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
    Robert R. Freedman
    Chris-Ellyn Johanson
    Manuel E. Tancer
    Psychopharmacology, 2005, 183 : 248 - 256
  • [48] Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment
    Bhattachary, S
    Powell, JH
    PSYCHOLOGICAL MEDICINE, 2001, 31 (04) : 647 - 658
  • [49] The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences
    Wyeth, Richard P.
    Mills, Edward M.
    Ullman, Alison
    Kenaston, M. Alexander
    Burwell, Johanna
    Sprague, Jon E.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 235 (01) : 33 - 38
  • [50] MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves
    Parrott, AC
    NEUROPSYCHOBIOLOGY, 2004, 50 (04) : 329 - 335